Transcriptional Targeting Approaches in Cardiac Gene Transfer Using AAV Vectors
Open Access
Abstract
Cardiac-targeted transgene delivery offers new treatment opportunities for cardiovascular diseases, which massively contribute to global mortality. Restricted gene transfer to cardiac tissue might protect extracardiac organs from potential side-effects. This could be mediated by using cis-regulatory elements, including promoters and enhancers that act on the transcriptional level. Here, we discuss examples of tissue-specific promoters for targeted transcription in myocytes, cardiomyocytes, and chamber-specific cardiomyocytes. Some promotors are induced at pathological states, suggesting a potential use as “induction-by-disease switches” in gene therapy. Recent developments have resulted in the identification of novel enhancer-elements that could further pave the way for future refinement of transcriptional targeting, for example, into the cardiac conduction system.Keywords
This publication has 66 references indexed in Scilit:
- Construction of PR39 recombinant AAV under control of the HRE promoter and the effect of recombinant AAV on gene therapy of ischemic heart diseaseExperimental and Therapeutic Medicine, 2012
- microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectorsGene Therapy, 2010
- Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distributionGene Therapy, 2010
- Long-term Outcomes in Individuals With Prolonged PR Interval or First-Degree Atrioventricular BlockJAMA, 2009
- Tissue specific promoters improve specificity of AAV9 mediated transgene expression following intra-vascular gene delivery in neonatal miceGenetic Vaccines and Therapy, 2008
- Human CMV immediate‐early enhancer: a useful tool to enhance cell‐type‐specific expression from lentiviral vectorsThe Journal of Gene Medicine, 2007
- Cardiomyocyte-specific Gene Expression Following Recombinant Adeno-associated Viral Vector TransductionJournal of Biological Chemistry, 2002
- Myosin heavy chain gene expression in human heart failure.Journal of Clinical Investigation, 1997
- Alternative RNA Splicing-Generated Cardiac Troponin T Isoform Switching: A Non-Heart-Restricted Genetic Programming Synchronized in Developing Cardiac and Skeletal MusclesBiochemical and Biophysical Research Communications, 1996
- α-myosin Heavy Chain Gene Regulation: Delineation and Characterization of the Cardiac Muscle-specific Enhancer and Muscle-specific PromoterJournal of Molecular and Cellular Cardiology, 1996